Highlights
KLSE: PHARMA (7081)       PHARMANIAGA BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
4.01   +0.18 (4.70%)  3.84 - 4.12  5,854,500
Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.

Financials


Market Cap: 1,049 Million

Market Cap 1,049 Million
NOSH 262 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 19-Jun-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 19-Jun-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  31-Mar-2020 [#1]

Latest Quarter: 31-Mar-2020 [#1]
Announcement Date 19-May-2020
Next Quarter: 30-Jun-2020
Est. Ann. Date: 23-Aug-2020
Est. Ann. Due Date: 29-Aug-2020
QoQ | YoY   112.54%  |    14.18%

Annual (Unaudited) ( EPS: -57.02, P/E: -7.03 )

Revenue | NP to SH 2,820,530  |  -149,219
RPS | P/RPS 1,077.75 Cent  |  0.37
EPS | P/E | EY -57.02 Cent  |  -7.03  |  -14.22%
DPS | DY | Payout % 8.47 Cent  |  2.11%  |  - %
NAPS | P/NAPS 1.29  |  3.12
YoY   -451.37%
NP Margin | ROE -5.30%  |  -44.33%
F.Y. | Ann. Date 31-Dec-2019  |  20-Feb-2020

T4Q Result ( EPS: -55.95, P/E: -7.17 )

Revenue | NP to SH 2,854,343  |  -146,437
RPS | P/RPS 1,090.67 Cent  |  0.37
EPS | P/E | EY -55.95 Cent  |  -7.17  |  -13.95%
DPS | DY | Payout % 8.48 Cent  |  2.11%  |  - %
NAPS | P/NAPS 1.34  |  3.00
QoQ | YoY   1.86%  |    -429.08%
NP Margin | ROE -5.14%  |  -41.83%
F.Y. | Ann. Date 31-Mar-2020  |  19-May-2020

Annualized Result ( EPS: 34.24, P/E: 11.71 )

Revenue | NP to SH 3,279,684  |  89,596
RPS | P/RPS 1,253.20 Cent  |  0.32
EPS | P/E | EY 34.24 Cent  |  11.71  |  8.54%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   160.04%  |    14.18%
NP Margin | ROE 2.73%  |  25.60%
F.Y. | Ann. Date 31-Mar-2020  |  19-May-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 19-May-2020 31-Mar-2020 1 819,921 30,880 22,415 22,399 15,673 350,047 69.98% 2.73% 6.40% 261,229 313.87 313.30 8.57 8.56 6.00 5.99 1.3400 1.34   115.01%   14.18% 31-Mar-2020 1.26 0.40 14.69 0.94 6.81% 4.76% 19-May-2020 1.88 0.60 21.93 1.40 4.56% 3.19%
31-Dec-2019 20-Feb-2020 31-Dec-2019 4 2,820,530 -191,865 -149,447 -149,219 22,177 336,573 - % -5.30% -44.33% 260,910 1,081.04 1,077.75 -57.19 -57.02 8.50 8.47 1.2900 1.29   -607.91%   -451.37% 31-Dec-2019 2.06 0.19 -3.60 1.60 -27.76% 4.13% 20-Feb-2020 2.04 0.19 -3.57 1.58 -28.04% 4.17%
31-Dec-2019 20-Nov-2019 30-Sep-2019 3 2,104,847 46,609 29,286 29,379 22,168 516,387 75.46% 1.39% 5.69% 260,802 807.07 804.28 11.26 11.23 8.50 8.47 1.9800 1.97   1.66%   -22.75% 30-Sep-2019 2.44 0.30 21.66 1.23 4.62% 3.48% 20-Nov-2019 2.21 0.27 19.62 1.12 5.10% 3.85%
31-Dec-2019 23-Aug-2019 30-Jun-2019 2 1,387,998 42,724 28,910 28,898 22,149 518,564 76.65% 2.08% 5.57% 260,585 532.65 530.37 11.09 11.04 8.50 8.46 1.9900 1.98   47.31%   25.75% 28-Jun-2019 2.84 0.53 25.61 1.43 3.90% 2.99% 23-Aug-2019 2.66 0.50 23.99 1.34 4.17% 3.20%
31-Dec-2019 16-May-2019 31-Mar-2019 1 786,108 30,243 19,648 19,617 15,630 528,825 79.68% 2.50% 3.71% 260,505 301.76 300.38 7.53 7.50 6.00 5.97 2.0300 2.02   -53.81%   11.55% 29-Mar-2019 2.27 0.75 30.14 1.12 3.32% 2.64% 16-May-2019 2.36 0.78 31.34 1.16 3.19% 2.54%
31-Dec-2018 21-Feb-2019 31-Dec-2018 4 2,384,956 70,220 43,230 42,468 41,621 509,862 98.01% 1.81% 8.33% 260,134 916.82 911.31 16.33 16.23 16.00 15.90 1.9600 1.95   11.67%   -21.10% 31-Dec-2018 2.78 0.30 17.03 1.42 5.87% 5.76% 21-Feb-2019 2.76 0.30 16.91 1.41 5.92% 5.80%
31-Dec-2018 19-Nov-2018 30-Sep-2018 3 1,788,312 58,280 38,660 38,031 36,401 522,618 95.71% 2.16% 7.28% 260,009 687.79 683.33 14.63 14.53 14.00 13.91 2.0100 2.00   65.50%   18.76% 28-Sep-2018 2.89 0.42 19.76 1.44 5.06% 4.84% 19-Nov-2018 3.09 0.45 21.13 1.54 4.73% 4.53%
31-Dec-2018 17-Aug-2018 30-Jun-2018 2 1,200,652 40,677 23,355 22,980 23,383 519,642 101.76% 1.95% 4.42% 259,821 462.11 458.78 8.84 8.78 9.00 8.94 2.0000 1.99   30.67%   -19.21% 29-Jun-2018 2.88 0.62 32.56 1.44 3.07% 3.13% 17-Aug-2018 3.11 0.67 35.16 1.56 2.84% 2.89%
31-Dec-2018 16-May-2018 31-Mar-2018 1 617,923 28,707 17,589 17,586 12,991 524,838 73.87% 2.85% 3.35% 259,821 237.83 236.11 6.77 6.72 5.00 4.96 2.0200 2.01   -67.33%   -7.07% 30-Mar-2018 4.28 1.80 63.23 2.12 1.58% 1.17% 16-May-2018 4.07 1.71 60.13 2.01 1.66% 1.23%
31-Dec-2017 27-Feb-2018 31-Dec-2017 4 2,323,960 73,064 55,087 53,823 49,314 526,888 91.62% 2.37% 10.22% 259,551 895.38 888.01 20.74 20.57 19.00 18.84 2.0300 2.01   68.08%   18.04% 29-Dec-2017 4.60 0.51 22.18 2.27 4.51% 4.13% 27-Feb-2018 4.04 0.45 19.48 1.99 5.13% 4.70%
31-Dec-2017 15-Nov-2017 30-Sep-2017 3 1,710,764 53,198 32,899 32,023 33,729 531,892 105.33% 1.92% 6.02% 259,460 659.36 653.70 12.34 12.24 13.00 12.89 2.0500 2.03   12.59%   -31.04% 29-Sep-2017 4.14 0.63 33.54 2.02 2.98% 3.14% 15-Nov-2017 3.82 0.58 30.95 1.86 3.23% 3.40%
31-Dec-2017 16-Aug-2017 30-Jun-2017 2 1,136,261 37,927 29,009 28,443 20,742 541,894 72.93% 2.55% 5.25% 259,279 438.24 434.18 10.97 10.87 8.00 7.93 2.0900 2.07   50.31%   -14.77% 30-Jun-2017 4.58 1.05 41.75 2.19 2.40% 1.75% 16-Aug-2017 4.19 0.96 38.20 2.00 2.62% 1.91%
31-Dec-2017 16-May-2017 31-Mar-2017 1 618,294 27,777 19,258 18,923 10,368 544,360 54.79% 3.11% 3.48% 259,219 238.52 236.26 7.30 7.23 4.00 3.96 2.1000 2.08   -58.50%   2.96% 31-Mar-2017 4.89 2.05 66.99 2.33 1.49% 0.82% 16-May-2017 4.72 1.98 64.66 2.25 1.55% 0.85%
31-Dec-2016 21-Feb-2017 31-Dec-2016 4 2,189,022 72,017 45,859 45,599 41,457 531,169 90.92% 2.09% 8.58% 259,107 844.83 836.44 17.60 17.42 16.00 15.84 2.0500 2.03   -1.80%   -45.74% 30-Dec-2016 5.30 0.63 30.12 2.59 3.32% 3.02% 21-Feb-2017 5.12 0.61 29.09 2.50 3.44% 3.13%
31-Dec-2016 21-Nov-2016 30-Sep-2016 3 1,606,206 67,948 46,759 46,435 33,667 530,907 72.50% 2.91% 8.75% 258,979 620.21 613.75 17.93 17.74 13.00 12.86 2.0500 2.03   39.14%   -31.70% 30-Sep-2016 5.58 0.90 31.12 2.72 3.21% 2.33% 21-Nov-2016 5.70 0.92 31.79 2.78 3.15% 2.28%
31-Dec-2016 19-Aug-2016 30-Jun-2016 2 1,090,991 48,025 34,111 33,374 23,302 524,041 69.82% 3.13% 6.37% 258,913 421.37 416.88 12.89 12.75 9.00 8.90 2.0240 2.00   81.59%   -30.49% 30-Jun-2016 5.50 1.31 42.67 2.72 2.34% 1.64% 19-Aug-2016 5.62 1.33 43.60 2.78 2.29% 1.60%
31-Dec-2016 13-May-2016 31-Mar-2016 1 559,195 26,538 18,470 18,379 10,354 515,906 56.34% 3.30% 3.56% 258,859 216.02 213.67 7.10 7.02 4.00 3.96 1.9930 1.97   -78.13%   -42.19% 31-Mar-2016 5.76 2.67 81.13 2.89 1.23% 0.69% 13-May-2016 5.60 2.59 78.87 2.81 1.27% 0.71%
31-Dec-2015 15-Feb-2016 31-Dec-2015 4 2,189,312 112,722 84,584 84,044 77,674 529,482 92.42% 3.86% 15.87% 258,915 845.57 836.55 32.46 32.11 30.00 29.68 2.0450 2.02   23.63%   -10.44% 31-Dec-2015 6.36 0.75 19.59 3.11 5.10% 4.72% 15-Feb-2016 6.19 0.73 19.07 3.03 5.24% 4.85%
31-Dec-2015 26-Nov-2015 30-Sep-2015 3 1,509,162 89,005 68,543 67,982 59,542 534,070 87.59% 4.54% 12.73% 258,880 582.96 576.66 26.26 25.98 23.00 22.75 2.0630 2.04   41.60%   18.96% 30-Sep-2015 6.50 1.12 24.75 3.15 4.04% 3.54% 26-Nov-2015 6.50 1.12 24.75 3.15 4.04% 3.54%
31-Dec-2015 17-Aug-2015 30-Jun-2015 2 984,749 63,668 48,568 48,011 36,234 527,991 75.47% 4.93% 9.09% 258,819 380.48 376.28 18.55 18.35 14.00 13.85 2.0400 2.02   51.01%   13.79% 30-Jun-2015 7.13 1.87 38.44 3.50 2.60% 1.96% 17-Aug-2015 5.65 1.48 30.46 2.77 3.28% 2.48%
31-Dec-2015 18-May-2015 31-Mar-2015 1 471,904 38,612 31,926 31,794 18,123 528,173 57.00% 6.77% 6.02% 258,908 182.27 180.32 12.28 12.15 7.00 6.93 2.0400 2.02   -66.12%   21.27% 31-Mar-2015 6.00 3.29 48.86 2.94 2.05% 1.17% 18-May-2015 6.91 3.79 56.27 3.39 1.78% 1.01%
31-Dec-2014 23-Feb-2015 31-Dec-2014 4 2,122,933 125,580 94,225 93,844 72,486 525,526 77.24% 4.44% 17.86% 258,880 820.05 811.19 36.25 35.86 28.00 27.70 2.0300 2.01   64.22%   70.01% 31-Dec-2014 4.58 0.56 12.63 2.26 7.91% 6.11% 23-Feb-2015 5.28 0.64 14.57 2.60 6.87% 5.30%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 1,495,830 87,726 57,604 57,147 41,429 507,513 72.50% 3.85% 11.26% 258,935 577.69 571.57 22.07 21.84 16.00 15.83 1.9600 1.94   35.45%   66.19% 30-Sep-2014 4.63 0.80 20.98 2.36 4.77% 3.46% 21-Nov-2014 4.45 0.77 20.16 2.27 4.96% 3.60%
31-Dec-2014 21-Aug-2014 30-Jun-2014 2 993,744 62,781 42,603 42,192 20,707 502,162 49.08% 4.29% 8.40% 258,846 383.91 379.72 16.30 16.12 8.00 7.91 1.9400 1.92   60.93%   37.72% 30-Jun-2014 4.61 1.20 28.28 2.38 3.54% 1.74% 21-Aug-2014 4.62 1.20 28.34 2.38 3.53% 1.73%
31-Dec-2014 14-May-2014 31-Mar-2014 1 468,672 38,159 26,646 26,217 10,352 515,022 39.49% 5.69% 5.09% 258,805 181.09 179.08 10.13 10.02 4.00 3.96 1.9900 1.97   -52.51%   5.84% 31-Mar-2014 4.46 2.46 44.03 2.24 2.27% 0.90% 14-May-2014 4.70 2.60 46.40 2.36 2.16% 0.85%
31-Dec-2013 24-Feb-2014 31-Dec-2013 4 1,946,639 92,997 56,761 55,200 41,477 486,754 75.14% 2.92% 11.34% 258,911 751.85 743.83 21.32 21.09 16.02 15.85 1.8800 1.86   60.53%   -10.55% 31-Dec-2013 4.45 0.59 20.87 2.37 4.79% 3.60% 24-Feb-2014 4.29 0.57 20.12 2.28 4.97% 3.73%
31-Dec-2013 19-Nov-2013 30-Sep-2013 3 1,378,779 59,990 35,494 34,387 25,427 473,857 73.95% 2.57% 7.26% 258,938 532.47 526.84 13.28 13.14 9.82 9.72 1.8300 1.81   12.24%   -50.63% 30-Sep-2013 4.82 0.91 36.30 2.63 2.76% 2.04% 19-Nov-2013 4.72 0.89 35.54 2.58 2.81% 2.08%
31-Dec-2013 16-Aug-2013 30-Jun-2013 2 937,972 46,529 31,324 30,636 17,661 481,681 57.65% 3.34% 6.36% 258,968 362.20 358.41 11.83 11.71 6.82 6.75 1.8600 1.84   23.68%   -31.00% 28-Jun-2013 4.49 1.24 37.95 2.41 2.63% 1.52% 16-Aug-2013 4.66 1.29 39.39 2.51 2.54% 1.46%
31-Dec-2013 15-May-2013 31-Mar-2013 1 500,339 36,924 25,153 24,771 8,825 484,829 35.63% 5.03% 5.11% 117,676 425.18 191.18 21.05 9.47 7.50 3.37 4.1200 1.85   -59.86%   -13.64% 29-Mar-2013 8.26 1.94 39.24 2.00 2.55% 0.91% 15-May-2013 9.26 2.18 43.99 2.25 2.27% 0.81%
31-Dec-2012 18-Feb-2013 31-Dec-2012 4 1,812,346 103,313 63,205 61,710 41,187 471,886 66.74% 3.49% 13.08% 117,677 1,540.10 692.51 52.44 23.58 35.00 15.74 4.0100 1.80   -11.39%   18.32% 31-Dec-2012 8.10 0.53 15.45 2.02 6.47% 4.32% 18-Feb-2013 7.80 0.51 14.87 1.95 6.72% 4.49%
31-Dec-2012 06-Nov-2012 30-Sep-2012 3 1,329,942 99,066 70,674 69,645 29,420 496,623 42.24% 5.31% 14.02% 117,683 1,130.10 508.18 59.18 26.61 25.00 11.24 4.2200 1.90   56.87%   73.18% 28-Sep-2012 7.55 0.67 12.76 1.79 7.84% 3.31% 06-Nov-2012 8.25 0.73 13.94 1.95 7.17% 3.03%
31-Dec-2012 08-Aug-2012 30-Jun-2012 2 903,482 70,573 45,138 44,398 17,650 481,282 39.76% 5.00% 9.22% 117,672 767.79 345.23 37.73 16.96 15.00 6.74 4.0900 1.84   54.78%   50.99% 29-Jun-2012 10.18 1.33 26.98 2.49 3.71% 1.47% 08-Aug-2012 8.83 1.15 23.40 2.16 4.27% 1.70%
31-Dec-2012 03-May-2012 31-Mar-2012 1 446,745 42,955 29,061 28,685 8,824 474,161 30.76% 6.51% 6.05% 117,657 379.70 170.71 24.38 10.96 7.50 3.37 4.0300 1.81   -45.00%   85.26% 30-Mar-2012 5.90 1.55 24.20 1.46 4.13% 1.27% 03-May-2012 5.90 1.55 24.20 1.46 4.13% 1.27%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 1,520,981 73,186 52,785 52,157 35,304 514,273 67.69% 3.47% 10.14% 117,682 1,292.44 581.18 44.32 19.93 30.00 13.49 4.3700 1.97   29.70%   71.66% 30-Dec-2011 5.36 0.41 12.09 1.23 8.27% 5.60% 22-Feb-2012 5.90 0.46 13.31 1.35 7.51% 5.08%
31-Dec-2011 01-Nov-2011 30-Sep-2011 3 1,153,195 56,818 40,603 40,215 - 464,307 - % 3.52% 8.66% 106,983 1,077.92 440.65 37.59 15.37 0.00 0.00 4.3400 1.77   36.77%   23.21% 30-Sep-2011 5.90 0.55 15.70 1.36 6.37% 0.00% 01-Nov-2011 5.90 0.55 15.70 1.36 6.37% 0.00%
31-Dec-2011 10-Aug-2011 30-Jun-2011 2 781,763 41,172 29,644 29,404 - 451,381 - % 3.79% 6.51% 106,962 730.88 298.72 27.49 11.24 0.00 0.00 4.2200 1.72   89.90%   22.24% 30-Jun-2011 5.90 0.81 21.46 1.40 4.66% 0.00% 10-Aug-2011 5.90 0.81 21.46 1.40 4.66% 0.00%
31-Dec-2011 13-May-2011 31-Mar-2011 1 385,328 21,792 15,599 15,484 - 437,661 - % 4.05% 3.54% 107,007 360.09 147.24 14.47 5.92 0.00 0.00 4.0900 1.67   -49.04%   66.37% 31-Mar-2011 5.73 1.59 39.60 1.40 2.53% 0.00% 13-May-2011 5.05 1.40 34.90 1.23 2.87% 0.00%
31-Dec-2010 25-Feb-2011 31-Dec-2010 4 1,378,348 45,462 30,310 30,384 10,698 421,524 35.21% 2.20% 7.21% 106,985 1,288.35 526.68 28.40 11.61 10.00 4.09 3.9400 1.61   -6.91%   -49.52% 30-Dec-2010 5.31 0.41 18.70 1.35 5.35% 1.88% 25-Feb-2011 5.35 0.42 18.84 1.36 5.31% 1.87%
31-Dec-2010 04-Nov-2010 30-Sep-2010 3 1,002,232 48,163 32,262 32,640 50,281 424,715 154.05% 3.22% 7.69% 106,981 936.83 382.96 30.51 12.47 47.00 19.21 3.9700 1.62   35.69%   -14.73% 30-Sep-2010 4.98 0.53 16.32 1.25 6.13% 9.44% 04-Nov-2010 4.92 0.53 16.13 1.24 6.20% 9.55%
31-Dec-2010 11-Aug-2010 30-Jun-2010 2 667,895 32,758 23,827 24,054 50,290 417,306 209.07% 3.57% 5.76% 107,001 624.19 255.21 22.48 9.19 47.00 19.22 3.9000 1.59   158.45%   -25.34% 30-Jun-2010 4.98 0.80 22.15 1.28 4.51% 9.44% 11-Aug-2010 4.95 0.79 22.02 1.27 4.54% 9.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  2 people like this.
 
hahasong China tried to steal American vaccines, but the plan failed!

The PLA spy Tang Juan was arrested by the FBI in the United States!

hahahaha. . . .

People who buy pharmaceutical stocks take care, haha

I bought the glove stocks Careplus and HLT, it will fly on Monday
01/08/2020 10:27 AM
lkheng Reuters: According to a Reuters report, sources from the US security services say a company targeted by two Chinese hackers indicted in the US earlier this month is Moderna, a leading coronavirus vaccine developer. How do you comment on this?

Wang Wenbin: Recently so-called sources from the US government have been accusing China of hacking to steal technology and data of US vaccine research, but there has been no evidence whatsoever. Such allegations are pure slander. The sources are all cited anonymously. The international community can see through such vilifying ploys.

As we've repeatedly said, China is leading the world in COVID-19 vaccine research and development. We don't need to get ahead by theft and we have never done that. On the contrary, we are worried about a certain thieving country stealing our technology by hacking.

We urge certain US government departments and individuals to stop smearing China with rumors. We also call on relevant media to deny such anonymous groundless disinformation platforms and channels for dissemination.
01/08/2020 4:34 PM
Newbiexxxxxxxxx https://www.google.com/amp/s/www.bloomberg.com/amp/news/articles/2020-08-01/russia-plans-to-roll-out-mass-covid-19-vaccinations-from-october
01/08/2020 7:53 PM
Value_Investor_888 Talk with the facts and figures for Pharma, the last quarter earning was superb at 8.57 sen as higher demands of it medicines/medical products from Malaysia & Indonesia BOOST up it earning. It for sure is one of the beneficiary of Covid-19 beside glove sector. When Vaccine of Covid-19 to be ready, may be just few months time before Trump election in Nov, this will be added advantages for it future earning!

With Q1 2020 of Earning @ 8.57 sen, annualized simply to be 34 sen.
With PE of 20, it worth RM6.80.
With PE of 30, it worth RM10.20!

So, share price of this counter is just recovering from it losses from previous sell off due to Q4 2019 bad quarter result. The reason of Q4 2019 bad results was due to full recognition on the remaining unamortised Pharmacy Information System (PhIS) costs. This represents a one-off non-cash item and will be better for the Group’s profitability moving forward as it will no longer need to bear this cost in the future!

Thus, Pharma currently just starts to go back to it previous glory. With it current supply of medicines and medical related products (including face mask..etc) to all the government clinics and hospitals in Malaysia and Indonesia (of course some private hospitals as well), this is enough to boost up it earning. The latest excellent earning results @ Q1 2020 has proven this!

Certainly, Covid-19 vaccine out will be added advantages for it future earning as it will be one of the government trusted pharmaceutical manufacturing facilities to handle the vaccine when available.

Link for latest News from Malay Mail: Pharmaniaga to grow manufacturing business, expand to Indonesia

https://www.malaymail.com/news/money/2020/07/21/pharmaniaga-to-grow-manufacturing-business-expand-to-indonesia/1886663

A very good reference for you all regarding history of H1N1 in 2009. Vaccine of H1N1 is available surprisingly in just around 8 months of time from US. Read the history as per below link which is from US CDC (Center of Disease Control):

https://www.cdc.gov/flu/pandemic-resources/2009-pandemic-timeline.html
Added covid-19 vaccine news tracker link as our daily reference/guideline on the latest vaccine progress:

https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html

APPROVAL:
Regulators in each country review the trial results and decide whether to approve the vaccine or not. During a pandemic, a vaccine may receive emergency use authorization before getting formal approval.
02/08/2020 12:45 PM
Allan2112 Monday will prove rhb alan lim talk shit
02/08/2020 4:14 PM
Keyman188 Coronavirus Vaccine Trials Advance in Race for Covid-19 Protection

Moderna, AstraZeneca and China's CanSino are among the leading candidates to produce a shot to fight the pandemic.

Updated: July 31, 2020, 9:45 PM


The global push to develop and secure coronavirus vaccines is accelerating, with researchers reporting positive developments in early studies and countries signing deals to lock up supplies.

More than 160 vaccines are under development globally, spurred by the U.S. government's Operation Warp Speed program and other fast-track initiatives. Shots from the University of Oxford with AstraZeneca Plc, Moderna Inc. and a partnership of Pfizer Inc. and BioNTech SE are among the vanguard. China's CanSino Biologics has received authorization for a limited deployment of its shot among the Chinese military, and the Russian Defense Ministry has suggested its state-backed vaccine candidate could soon be ready for use.

Progress on treating those already infected has been slower, with Gilead Sciences Inc.'s remdesivir receiving an emergency use authorization in the U.S. and decades-old generic drug dexamethasone showing promise in studies. Here's the current state of play on vaccines and treatments.


##https://www.bloomberg.com/features/2020-coronavirus-drug-vaccine-status/?srnd=premium-asia
02/08/2020 6:58 PM
James89 Worldwide supply may not reach 1 billion doses until the first quarter of 2022, Airfinity forecasts.

Investing in production capacity all over the world is seen as one of the keys to solving the dilemma, and pharma companies are starting to outline plans to deploy shots widely. Sanofi and Glaxo intend to provide a significant portion of worldwide capacity in 2021 and 2022 to a global initiative that’s focused on accelerating development and production and distributing shots equitably.

https://www.google.com.my/amp/s/www.bloomberg.com/amp/news/articles/2020-08-02/when-it-comes-to-covid-vaccines-rich-nations-are-first-in-line
02/08/2020 7:45 PM
chopstick https://www.foxnews.com/world/russia-coronavirus-vaccine-october-doctors-teachers
02/08/2020 8:12 PM
targetinvest Today run above RM4 and solidify this place
03/08/2020 9:13 AM
BursaFly The way of trader trade obviously they attract new blood to take their share, I would say not time to collect at this price range
03/08/2020 9:44 AM
BursaFly So don't be cheated at this price range, could be further down
03/08/2020 9:45 AM
James89 Someone is silently collecting this counter. Watch out after glove mania this will fly to moon.
03/08/2020 10:29 AM
profitgrow sudden up a lot
03/08/2020 10:49 AM
Win288288 kasi 5 mari la
03/08/2020 10:54 AM
wallstreetrookie I want to ask a really important question. Did Pharma ever hit limit up during its spike on 22nd July? Anyone who answers my question will definitely get good karma and blessed with more gains in the future.
03/08/2020 12:05 PM
wallstreetrookie This will influence one of my trading decisions in glove counters
03/08/2020 12:08 PM
targetinvest Soon Pharma will be moving like adventa
03/08/2020 12:16 PM
targetinvest Due to share issue not so much.. once a major big move come in.. it will burst for 1 day limit up
03/08/2020 12:17 PM
targetinvest Any price below RM 4.00, just buy and invest and keep long long.. target RM10 also easy happen
03/08/2020 12:17 PM
James89 wallstreetrookie I want to ask a really important question. Did Pharma ever hit limit up during its spike on 22nd July? Anyone who answers my question will definitely get good karma and blessed with more gains in the future.

Yes it did limit up for 2 days. Together with DPharma.
03/08/2020 12:34 PM
James89 targetinvest Due to share issue not so much.. once a major big move come in.. it will burst for 1 day limit up

Very true. The price movement if you compare with Dpharma is more aggressive (both ways).
03/08/2020 12:36 PM
targetinvest Pharma going to release 2Q report card
And it will confirm boom... now is just washing cards..
03/08/2020 12:37 PM
targetinvest I already study on all medical related companies..
Most hit limit up at least once.. then consolidate.. then another level higher after that..

Since pharma is nearing the qr report.. shud be very fast..

A good example is adventa... this one hit 3 days limit up.. then quiet down.. now ? limit up again..
03/08/2020 12:53 PM
targetinvest The reason is very simple... the stock valuation is just too cheap to justify for this scenario, and the earning will be explosive..
another issue is that there is nothing better to goreng and invest since all other industry will be lackluster.. so better pile all money here..

Hence cannot be value based on x10 x20 PE.. it can go to as high as x50 x60 pe because there is nothing out there better to invest than medical line..

The current season is definitely not for property, or bank, or some manufacturing that are affected. airlines are dead, tourism dead, shipping needless to say..

so when all those money losses at those sector want to recover, only way is to pile in to healthcare.. PE x50 x 60 x 70 also nobody will care so much
03/08/2020 12:55 PM
James89 @targetinvest Expect to hear more vaccine news in mid August onwards. This will greatly affect the price movement.
03/08/2020 12:55 PM
targetinvest EPS projection 40 cents for this year
X PE 80 = RM 32

U dun believe will come?
03/08/2020 12:57 PM
James89 Health-care limit up has no logic nowadays. Hence conservative PE calculation may not be applicable. When China start reporting good news on the vaccine then you know how hot this counter will be. Patience is the key!
03/08/2020 1:37 PM
Eric1969 Fly Pharma fly
03/08/2020 2:07 PM
targetinvest https://klse.i3investor.com/blogs/targetinvest/2020-08-03-story-h1511499819-Coronavirus_covid_19_created_a_vaccine_business_worth_USD936_billion_ye.jsp
03/08/2020 2:12 PM
targetinvest Global vaccine business increase by usd 930 billion
03/08/2020 2:13 PM
targetinvest Malaysia + Indonesia
smelly smelly also got RM 140 billion
03/08/2020 2:41 PM
targetinvest last call already... below rm4 maybe this week is final after that no more
03/08/2020 2:44 PM
targetinvest Invest 40k also will get RM 400k in 1 year...
03/08/2020 2:45 PM
James89 Rocket soon?
03/08/2020 2:48 PM
James89 I have not collected enough. Please wait for awhile ba
03/08/2020 2:50 PM
Win288288 just in while available, train dont wait for late passenger
03/08/2020 2:51 PM
targetinvest Maybe 4pm rocket... all collection very goood
03/08/2020 3:10 PM
targetinvest all healthcare also 7788 limit up one after another..
Do facemask also limit up..

this do healthcare provide to government... how can sit there and sleep?
03/08/2020 3:16 PM
James89 Remember few bitter IBs said pharma n dpharma with potential market in ASEAN are over valued.. Facemask, hospital bed, small cap glove all fair price hahaha
03/08/2020 3:32 PM
targetinvest Get ready pecutan 100meter
03/08/2020 3:38 PM
targetinvest Yea IB all cheater.. purposely go and value glove share margin value to low low and cause panic.. in the end??? Wad happen?
03/08/2020 3:39 PM
targetinvest That time first margin value topglove RM 8...
Now?
03/08/2020 3:41 PM
Win288288 those sarung tangan lovers tot they will stay high forever, later will cry to buy here wakaka
03/08/2020 4:25 PM
targetinvest Government spending top money to pharma to stock up medical supplies..
Q2 prepare boom above 10 cents eps
03/08/2020 5:04 PM
Reiko8 @wim288288 which mean u r not buying this stock?
03/08/2020 5:17 PM
Win288288 @Reiko8 proud to say, i already earned my modal from initial buy in 2.25 last time. wakakaka
03/08/2020 5:23 PM
Reiko8 @win288288 wow...should I buy with this @4 price?
03/08/2020 5:27 PM
denzadesu wohoo, at last, people start to get their sense, other glove and mask counter over hot, despite vaccine news everywhere oversea. Buy some for later
03/08/2020 7:08 PM
Whoisthis Hahaha hoh seh liao..
03/08/2020 7:45 PM
chtan33 Remember ...... gloves took Jan to Apr to warm up engine,,,, before finally took off
03/08/2020 11:35 PM